For 3QFY2017 Lupin posted results much better than expected on sales and OPM fronts. In sales, the company posted sales of Rs4,110cr v/s Rs4,000cr expected yoy growth of 31.3%. The strong sales growth was aided by the USA (contributed around 49.0%), which registered a yoy growth of 57.6%. On EBITDA front, the company posted EBITDA of 25.9..